GF Fund Management’s Avidity Biosciences RNAM Stock Holding History

GF Fund Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,961	Closed	-$214K	–	653
2025 Q4	$214K	Buy	2,961 +193	+7%	+$12.5K	﹤0.01%	288
2025 Q3	$121K	Sell	2,768 -287	-9%	-$11.6K	﹤0.01%	325
2025 Q2	$86.8K	Hold	3,055	–	–	﹤0.01%	378
2025 Q1	$90.2K	Buy	3,055 +550	+22%	+$17.1K	﹤0.01%	371
2024 Q4	$72.8K	Buy	+2,505	New	+$105K	﹤0.01%	357

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

GF Fund Management's RNAM Position: Q1 2026 in Review

GF Fund Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,961 shares — an estimated $214K sold.

GF Fund Management first reported a position in RNAM in Q4 2024 and held it in 5 quarters. The position peaked at $214K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

GF Fund Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
GF Fund Management sold 2,961 Avidity Biosciences shares in Q1 2026, an estimated $214K.
GF Fund Management first reported a position in Avidity Biosciences in Q4 2024 and held it in 5 quarters.
GF Fund Management's Avidity Biosciences position peaked at $214K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.